Publications
Many of the findings from research studies and projects that Penn Vasculitis Center providers have participated in are published in a variety of important scientific journals. We are only able to do these studies because of the patients who volunteer.
Search for publications by clicking on a disease in the drop down below.
“Title of publication” |
Penn investigators involved (*lead) |
What we learned |
---|---|---|
“Avacopan for the Treatment of ANCA-Associated Vasculitis” |
Dr. Peter Merkel* |
|
“Plasma exchange and glucocorticoids in severe ANCA-associated vasculitis” |
Dr. Peter Merkel* |
|
“Characterisation of the nasal microbiota in granulomatosis with polyangiitis” |
Dr. Rennie Rhee* |
|
“Validation of the ANCA-associated vasculitis patient-reported outcomes (AAV-PRO) questionnaire” |
Dr. Peter Merkel* |
|
“Mepolizumab or placebo for eosinophilic granulomatosis with polyangiitis” |
Dr. Peter Merkel* |
|
“Identification of functional and expression polymorphisms associated with risk for ANCA-associated vasculitis” |
Dr. Peter Merkel* |
|
“Title of publication” |
Penn investigators involved (*lead) |
What we learned |
---|---|---|
“A randomized, double-blind trial of abatacept (CTLA-4Ig) for the treatment of giant cell arteritis” |
Dr. Peter Merkel* |
|
“Infections and the risk of incident giant cell arteritis: a population-based, case-control study” |
Dr. Rennie Rhee* |
|
“Title of publication” |
Penn investigators involved (*lead) |
What we learned |
---|---|---|
“Effect of treatment on imaging, clinical, and serologic assessments of disease activity in large-vessel vasculitis" |
Dr. Shubhasree Banerjee* |
|
“A randomized, double-blind trial of abatacept (CTLA-4Ig) for the treatment of Takayasu arteritis” |
Dr. Peter Merkel* |
|
“Title of publication” |
Penn investigators involved (*lead) |
What we learned |
---|---|---|
“Patient perception of disease-related symptoms and complications in relapsing polychondritis” |
Dr. Shubhasree Banerjee* |
|
“Title of publication” |
Penn investigators involved (*lead) |
What we learned |
---|---|---|
“Sequence-based screening of patients with idiopathic polyarteritis nodosa, granulomatosis with polyangiitis, and microscopic polyangiitis for deleterious genetic variants in ADA2” |
Dr. Peter Merkel* |
|
“Comparison of aortitis vs noninflammatory aortic aneurysms among patients who undergo open aortic aneurysm repair” |
Dr. Rennie Rhee* |
|